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In order to optimize health outcomes
within the constraints of inevitably limited
resources, low- and high-income countries
alike require unbiased means of assessing
health care interventions for their relative
effectiveness. Such interventions include
diagnostic tests and treatments (both
established and newly developed) and
implementation of health policy [1].
Likewise, health care professionals and
patients need better information to inform
health care decisions that require weigh-
ing benefits and risks in light of the
patient’s medical history and personal
preferences.
Some countries and international orga-
nizations have recognized the need for
such evidence and are already allocating
funds for research to provide it [2]. The
WHO Ministerial Summit in Mexico
called for the establishment of support
for a substantive and sustainable program
of health systems research aligned with
countries’ priority needs and aimed at
achieving internationally agreed-upon
health-related development goals, includ-
ing those contained in the United Nations
Millennium Declaration [3]. The UK has
established the National Institute for
Health Research to commission and
disseminate research that supports deci-
sion making by professionals, policy
makers and patients and to ensure that
the UK’s health system, the National
Health Service, has access to the best
possible evidence to inform decisions and
choices [4].
The US is now addressing similar goals
with an initiative known as comparative
effectiveness research (CER). In 2008, a
report by the US Institute of Medicine
(IOM) noted that patient care ‘‘should
be based on the conscientious, explicit,
and judicious use of current best evidence’’
[1]. In legislation that allocated US $1.1
billion in the US for CER on health
care practices in 2009, the US Congress
mandated that the IOM set national
priorities for CER clinical topics. The
IOM defined CER as ‘‘The generation
and synthesis of evidence that compares
the benefits and harms of alternative
methods to prevent, diagnose, treat, and
monitor a clinical condition, or to improve
the delivery of care’’ [5]. The definition
further stated that ‘‘The purpose of CER
is to assist consumers, clinicians, purchas-
ers, and policy makers to make informed
decisions that will improve health care at
both the individual and population levels.’’
To the authors and endorsers of the
present Editorial, the potential value of
research with these characteristics is self-
evident. The challenge will be to realize
the full potential of such research to
improve health. Doing so will require
assessing a heterogeneous body of evi-
dence consisting of prospective random-
ized trials—including pragmatic trials—
and observational research using data
obtained in the course of regular practice.
Hence, medical journals must use rigorous
approaches, including but not limited to
peer review by independent experts, to
assess the limitations inherent in such
research, such as missing data, incomplete
follow-up, unmeasured biases, the poten-
tial role of chance, competing interests,
and selective reporting of results.
Drawing on many years of collective
experience in assessing these issues in
the course of evaluating health research
through peer review, we support the
following principles and standards for CER.
Principles of CER
N The principal goal of CER is to allow
decision makers (patients, clinicians,
purchasers, and policy makers) to
make informed decisions on specific
health practices. CER aims to identify
and fill knowledge gaps that underlie
uncertainties in practice.
N CER may provide information about
individual and population benefits,
harms, costs, and logistics of different
policies or treatments.
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interventions, tests, and strategies for
prevention, care delivery, and quality
of care
N CER should directly compare tests or
active treatments—so-called head-to-
head comparisons—of viable clinical
alternatives within the current stan-
dard of practice (which in some cases
may be no intervention).
N CER should primarily assess patient-
relevant outcomes, but should also
compare the economic implications
of different approaches to prevention
and care.
N CER should assist patients and physi-
cians to choose between effective
treatments. To this end, CER should
identify patient characteristics that are
associated with meaningful differences
in outcomes. Researchers should col-
lect and analyze the data necessary to
achieve this goal according to a pre-
specified plan that clearly indicates
specific hypotheses and the methods
to test them.
N The scope of CER includes new data,
old data newly analyzed, and system-
atic reviews of existing research.
Standards for the Conduct and
Reporting of CER
N CER studies should follow the highest
scientific standards for design, analysis,
and interpretation and should adhere
to reporting guidelines [6] that build
upon initiatives to improve the quality
and transparency of clinical science.
N Every CER study should have a
research protocol, written in advance
and addressing the key research ques-
tion(s), methods, and planned analyses.
Researchers should record all changes
in the protocol. These protocols should
be publicly accessible.
N Patients and other decision-makers
should be involved in selecting and
refining topics for CER.
N The study population for CER should
be representative of clinical practice or
the relevant public health practice.
N To increase transparency about selec-
tive publication, researchers should
register CER studies before initiation,
in a publicly available registry.
N To increase transparency about the
practice of presenting post-hoc analy-
ses as conclusive results, study regis-
tration should include a clear state-
ment of study hypotheses, outcomes,
and analysis plan.
N CER studies must undergo rigorous
peer review by independent topical,
methodological, and statistical experts.
N To ensure accessibility to the affected
public and other researchers, journals
(or other sites of publication) should
make all CER studies freely available
and archive them in a public reposito-
ry, such as PubMed Central.
N Reports of CER must include a frank
discussion of each study’s limitations,
including biases, confounding, and
scope of applicability.
N Given the potential impact of CER on
the profitability of the interventions
being evaluated, researchers perform-
ing CER studies must commit to
stringent and enforceable competing
interest policies [7].
N Researchers, funders, and other con-
tributors to a CER study must clearly
state all relevant competing interests at
the time of peer review, and publicly
upon publication in any forum.
Medical journals are the primary eval-
uators and disseminators of peer-reviewed
health research. As such, they must ready
themselves to play a crucial role in
advocating for CER, advancing CER
methods and facilitating the translation
of CER results into practice. Most impor-
tantly, journals and peer reviewers must
do their part to ensure that CER, like all
research with relevance to health, meets
the highest scientific and ethical standards.
They must therefore develop the method-
ological and statistical expertise to prop-
erly evaluate new or unfamiliar methods of
health care research.
We recognize that CER has the poten-
tial to substantially improve decision-
making about existing and new approach-
es to health care. To fulfill this potential,
researchers must adopt stringent methods,
and medical journals must hold them to
high standards of ethics, scientific rigor,
and reporting.
Acknowledgments
The authors acknowledge the following editors
who have endorsed this statement: Richard L.
Kravitz and Mitchell D. Feldman, Co-Editors
in Chief, Journal of General Internal Medicine;A .
Mark Fendrick and Michael Chernew, Co-
Editors in Chief, The American Journal of Managed
Care; Arthur Feldman, Editor-in-Chief, Clinical
and Translational Science; Ana Marusic, Editor in
Chief, Croatian Medical Journal.
Author Contributions
ICMJE criteria for authorship read and met:
HCS MH JG KD VB JC SJ LP EV DT AK PT.
Agree with the manuscript’s results and conclu-
sions: HCS MH JG KD VB JC SJ LP EV DT
AK PT. Wrote the first draft of the paper: HCS.
Contributed to the writing of the paper: HCS
MH JG KD VB JC SJ LP EV DT AK PT.
References
1. Eden J, Wheatley B, McNeil B, Sox H, eds;
Committee on Reviewing Evidence to Identify
Highly Effective Clinical Services, Institute of
Medicine (2008) Knowing What Works in Health
Care: A Roadmap for the Nation. Washington,
DC: National Academy Press, Available: http://
www.nap.edu/catalog.php?record_id=12038.
Accessed: 26 March 2010.
2. Moynihan R, Oxman AD, Lavis JN, Paulsen E
(2008) Evidence-Informed Health Policy: Using
Research to Make Health Systems Healthier.
Rapport Nr 1-2008. Oslo: Nasjonalt kunnskaps-
senter for helsetjenesten.
3. WHO (2005) WHA 58.34 Ministerial Summit on
Health Research. Available: http://apps.who.
int/gb/ebwha/pdf_files/WHA58/WHA58_34-
en.pdf. Accessed 30 November 2009.
4. UK Department of Health (2006) Best Research
for Best Health: A new national health research
strategy. Report 272605. Available: http://
www.dh.gov.uk/en/Publicationsandstatistics/
Publications/PublicationsPolicyAndGuidance/
DH_4127127. Accessed: 26 March 2010.
5. IOM (Institute of Medicine) (2009) Initial Na-
tional Priorities for Comparative Effectiveness
Research. Washington, DC: National Academy
Press, Available: http://www.nap.edu/catalog.
php?record_id=12648. Accessed: 26 March
2010.
6. Simera I, Altman DG, Moher D, Schulz KF,
Hoey J (2008) Guidelines for reporting health
research: The EQUATOR network’s survey of
guideline authors. PLoS Med 5: e139.
doi:10.1371/journal.pmed.0050139.
7. PLoS Medicine (2009) Ensuring Integrity in
Comparative Effectiveness Research: Accentuate
the Negative. PLoS Med 6: e1000152.
doi:10.1371/journal.pmed.1000152.
PLoS Medicine | www.plosmedicine.org 2 April 2010 | Volume 7 | Issue 4 | e1000269